Translating UK scientific excellence in global therapeutics strategies
Meet Jérôme Pesenti, CEO BenevolentTech at Viva Technology in Paris
Join a select group of 250 practitioners, researchers, entrepreneurs and investors to explore current and future industry applications of groundbreaking new technologies in healthcare.
Solving the world’s most pressing challenges through open innovation and partnership.
Only 1 in 5,000 medicines in development make it to market, with a drug typically taking 12 years to develop from initial discovery to market. Estimates vary but the Association of the British Pharmaceutical Industry puts drug development at £1.15bn per drug.
BenevolentAI Team will be attending the event, get in touch!
Join fellow developers, startups, academics and investors at the second edition of Project Juno's event to highlight the breadth and depth of machine intelligence activity and talent in Europe.
Professor Jackie Hunter has been invited to speak at this year's TechCrunch Disrupt event in London
NIPS is coming to Europe between 5th and 10th December in Barcelona – meet us there, talk to us about the world of AI and maybe joining the team
hosted by BenevolentAI
with Professor Jackie Hunter, CEO at Stratified Medical, a BenevolentAI company
by Dr Jeffrey Ng, CTO at BenevolentAI - IntelliSys 2015
with Dr John P. Overington, Director of Bioinformatics, BenevolentBio